Abuse-resistant drug delivery

Psychiatric Annals

Volumn 35, Issue 3, 2005, Pages 253-256

  DuPont, Robert L ^a,b   Bensinger, Peter B ^c  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Bensinger DuPont and Associates   (United States)

^c DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; COCAINE; DEXAMPHETAMINE; METHYLPHENIDATE; MOOD STABILIZER; NARCOTIC ANALGESIC AGENT; OPIATE DERIVATIVE; PSYCHOSTIMULANT AGENT;

ACADEMIC ACHIEVEMENT; ATTENTION DEFICIT DISORDER; COCAINE DEPENDENCE; COLLEGE STUDENT; CONTROLLED DRUG RELEASE; DISEASE RESISTANCE; DRUG ABSORPTION; DRUG ABUSE; DRUG ABUSE PATTERN; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG MECHANISM; DRUG UTILIZATION; HUMAN; PRESCRIPTION; REVIEW; RISK REDUCTION; SLOW DRUG RELEASE;

EID: 16244401149     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (5)

1. Weiss N. Academic performance-enhancing drugs: The Stanford steroid. The Stanford Daily [Web site]. November 5, 2004. Available at: http://daily. stanford.edu/tempo?page=content&id=15181&repository=0001_article. Accessed February 4, 2005.
2. Acker CJ. Creating the American Junkie: Addiction Research in the Classic Era of Narcotic Control. Baltimore, MD: The Johns Hopkins University Press; 2002.
3. Volkow ND, Swanson JM. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry. 2003;160(11):1909-1918.
4. Zamiska N. Pressed to do well on admissions tests, students take drugs. The Wall Street Journal. November 8, 2004:A1.
5. Cone EJ, Fant RV, Rohay JM, et al. Oxycodone involvement in drug abuse deaths: a DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases. J Anal Toxicol. 2003;27(2):57-67.